During the last session, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares were 0.54 million, with the beta value of the company hitting 0.38. At the end
In the last trading session, 1.42 million shares of the ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) were traded, and its beta was 0.46. Most recently the company’s
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares stood at 1.5 million during the last session, with the company’s beta value hitting 0.38. At the close of
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares stood at 45.85 million during the last session, with the company’s beta value hitting 0.38. At the close of
In the last trading session, 1.01 million ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) shares changed hands as the company’s beta touched 0.36. With the company’s per share
In last trading session, ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) saw 0.85 million shares changing hands with its beta currently measuring 0.35. Company’s recent per share price
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) has a beta value of 0.35 and has seen 1.11 million shares traded in the last trading session. The company, currently
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares stood at 0.76 million during the last session, with the company’s beta value hitting 0.34. At the close of
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s traded shares stood at 1.12 million during the last session, with the company’s beta value hitting 0.34. At the close of
In the last trading session, 1.03 million ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) shares changed hands as the company’s beta touched 0.20. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
